Chile’s Pension Risk Rating Commission Approves Sale of Four Additional First Trust ETFs
“Chile’s pension system continues to grow and expand and we are excited and privileged to grow alongside it,” said
Newly Approved
First Trust Value Line®
First Trust Energy AlphaDEX® Fund (FXN)
Previously Approved
First Trust Large Cap Value AlphaDEX® Fund (FTA)
First Trust Large Cap Core AlphaDEX® Fund (FEX)
First Trust Consumer Discretionary AlphaDEX® Fund (FXD)
First Trust Health Care AlphaDEX® Fund (FXH)
First Trust Financials AlphaDEX® Fund (FXO)
First Trust Europe AlphaDEX® Fund (FEP)
For more information about
About
You should consider a fund’s investment objectives, risks, and charges and expenses carefully before investing. Contact
Risk Considerations
Investors buying or selling fund shares on the secondary market may incur customary brokerage commissions. Shares may only be redeemed directly from a fund by authorized participants in very large creation/redemption units. Fund shares may trade at a discount to net asset value and possibly face delisting.
There are risks involved with investing in ETFs, including the potential loss of money. Index-based ETFs are not actively managed and may not match the return of the specific index it seeks to replicate.
There is no assurance that any funds listed will achieve their investment objectives. Please be aware that each fund listed is subject to various risks which, depending on the investment objective, may include risks such as concentration, sector, momentum investing, equity investing, and foreign and emerging markets. For a complete description of relative risks for a specific fund please obtain and carefully read the appropriate
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information,
The Dow Jones Internet Composite IndexSM is a product of
"AlphaDEX®" is a registered trademark of
The
"Value Line®" and "Value Line® Dividend Index" are trademarks or registered trademarks of Value Line, Inc. ("Value Line") and have been licensed for use for certain purposes by
The NYSE Arca Biotechnology IndexSM is a trademark of the
Nasdaq®, NASDAQ-100®, NASDAQ-100 Index®, and NASDAQ-100 Technology Sector IndexSM are trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the "Corporations") and are licensed for use by
The views and opinions expressed are for informational purposes only. This material is not intended to be relied upon as investment advice or recommendations, does not constitute a solicitation to buy or sell securities (in any jurisdiction to any person to whom it is not lawful to make such an offer) and should not be considered specific legal, investment or tax advice.
For Investors in
The offer in
Esta oferta en
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030006303/en/
[email protected]
Source:
XYZ Market Growth to Be Benefited by Technological Advancements by 2025
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News